These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26690378)

  • 1. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.
    Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D
    Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitoxin Use in the Prevention and Treatment of Anthrax Disease: A Systematic Review.
    Hesse EM; Godfred-Cato S; Bower WA
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S432-S440. PubMed ID: 36251559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident.
    Bower WA; Hendricks K; Pillai S; Guarnizo J; Meaney-Delman D;
    MMWR Recomm Rep; 2015 Dec; 64(4):1-22. PubMed ID: 26632963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018.
    Person MK; Cook R; Bradley JS; Hupert N; Bower WA; Hendricks K
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S392-S401. PubMed ID: 36251553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review.
    Pillai SK; Huang E; Guarnizo JT; Hoyle JD; Katharios-Lanwermeyer S; Turski TK; Bower WA; Hendricks KA; Meaney-Delman D
    Health Secur; 2015; 13(6):355-64. PubMed ID: 26623698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obiltoxaximab (Anthim) for inhalation anthrax.
    Med Lett Drugs Ther; 2018 Sep; 60(1555):150-151. PubMed ID: 30383733
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
    Hendricks KA; Wright ME; Shadomy SV; Bradley JS; Morrow MG; Pavia AT; Rubinstein E; Holty JE; Messonnier NE; Smith TL; Pesik N; Treadwell TA; Bower WA;
    Emerg Infect Dis; 2014 Feb; 20(2):. PubMed ID: 24447897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal-to-Human Dose Translation of ANTHRASIL for Treatment of Inhalational Anthrax in Healthy Adults, Obese Adults, and Pediatric Subjects.
    Beliveau M; Rubets I; Bojan D; Hall C; Toth D; Kodihalli S; Kammanadiminti S
    Clin Pharmacol Ther; 2024 Feb; 115(2):248-255. PubMed ID: 38082506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection.
    Hou AW; Morrill AM
    Ann Pharmacother; 2017 Oct; 51(10):908-913. PubMed ID: 28573869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of the Efficacy of FDA-Approved
    Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does anthrax antitoxin therapy have a role in the treatment of inhalational anthrax?
    Vietri NJ
    Curr Opin Infect Dis; 2018 Jun; 31(3):257-262. PubMed ID: 29570493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; O'Connor E; Gonzales N; Mondick J; French J; Stark GV; Fisher AC; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5787-95. PubMed ID: 27431222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax Antitoxins.
    Slay RM; Cook R; Hendricks K; Boucher D; Merchlinsky M
    Clin Infect Dis; 2022 Oct; 75(Suppl 3):S441-S450. PubMed ID: 36251555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
    Bower WA; Yu Y; Person MK; Parker CM; Kennedy JL; Sue D; Hesse EM; Cook R; Bradley J; Bulitta JB; Karchmer AW; Ward RM; Cato SG; Stephens KC; Hendricks KA
    MMWR Recomm Rep; 2023 Nov; 72(6):1-47. PubMed ID: 37963097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating Anthrax-Induced Meningitis in Rabbits.
    Ben-Shmuel A; Glinert I; Sittner A; Bar-David E; Schlomovitz J; Brosh T; Kobiler D; Weiss S; Levy H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obiltoxaximab: First Global Approval.
    Greig SL
    Drugs; 2016 May; 76(7):823-30. PubMed ID: 27085536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pre-approved and novel therapies for the treatment of anthrax.
    Head BM; Rubinstein E; Meyers AF
    BMC Infect Dis; 2016 Nov; 16(1):621. PubMed ID: 27809794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric anthrax clinical management: executive summary.
    Bradley JS; Peacock G; Krug SE; Bower WA; Cohn AC; Meaney-Delman D; Pavia AT;
    Pediatrics; 2014 May; 133(5):940-2. PubMed ID: 24777221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.